Post-mortem findings in a patient with avian influenza A (H5N6) virus infection

Clinical Microbiology and Infection

Volumn 22, Issue 6, 2016, Pages 574.e1-574.e5

  Gao, R ^a   Pan, M ^b   Li, X ^a   Zou, X ^a   Zhao, X ^a   Li, T ^b   Yang, H ^b   Zou, S ^a   Bo, H ^a   Xu, J ^b   Li, S ^b   Zhang, M ^c   Li, Z ^d   Wang, D ^a   Zaki, S R ^e   Shu, Y ^a  

^a China CDC   (China)

^b Sichuan Provincial Center for Disease Control and Prevention   (China)

^c Nanchong City Disease Control and Prevention   (China)

^d Affiliated Hospital of Chuanbei Medical School   (China)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

H5N6; highly pathogenic avian influenza virus; histology; immunopathological lesion; severe pneumonia

Indexed keywords

EOSIN; HEMATOXYLIN; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; SIALIDASE;

ADULT; ARTICLE; AUTOPSY; AVIAN INFLUENZA; AVIAN INFLUENZA A (H5N6); BRAIN; CADAVER; CASE REPORT; CLINICAL FEATURE; COUGHING; DESQUAMATION; DISEASE EXACERBATION; FATALITY; FEVER; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INFLUENZA A VIRUS; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H5N6); LIVER CELL; LUNG ALVEOLUS CELL; LUNG EDEMA; LUNG HEMORRHAGE; LUNG LYMPH; LUNG PARENCHYMA; LYMPHOCYTE; MALE; MIDDLE AGED; MONONUCLEAR CELL; NERVE CELL DEGENERATION; PRIORITY JOURNAL; PULMONARY VASCULITIS; RESPIRATORY FAILURE; VIRUS PATHOGENESIS; ANIMAL; CHINA; CLASSIFICATION; INFLUENZA; ISOLATION AND PURIFICATION; LUNG; PATHOLOGY; VIROLOGY;

ANIMALS; AUTOPSY; BRAIN; CHINA; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG; MALE; MIDDLE AGED; NEURAMINIDASE;

EID: 84975105722     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2016.03.017     Document Type: Article

References (15)

1. [1] Pan, M., Gao, R., Lv, Q., Huang, S., Zhou, Z., Yang, L., et al. Human infection with a novel highly pathogenic avian influenza A (H5N6) virus: virological and clinical findings. J Infect 72 (2015 Jul 2), 52–59.
2. [2] CIDRP, H5N6 sickens another in China as Egypt notes 2 H5N1 cases. 2016 http://wwwcidrapumnedu/news-perspective/2016/03/h5n6-sickens-another-china-egypt-notes-2-h5n1-cases.
3. [3] Yang, Z.F., Mok, C.K., Peiris, J.S., Zhong, N.S., Human infection with a novel avian influenza A(H5N6) virus. N Engl J Med 373 (2015 Jul 30), 487–489.
4. [4] Gu, J., Xie, Z., Gao, Z., Liu, J., Korteweg, C., Ye, J., et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370 (2007 Sep 29), 1137–1145.
5. [5] Kitaura, Y., Deguchi, H., Terasaki, F., Ukimura, A., Morita, H., Tatsumi, T., [Influenza myocarditis–pathophysiology and developmental mechanism of myocarditis]. Nihon rinsho Jpn J Clin Med 61 (2003 Nov), 1945–1952.
6. [6] Bellomo, R., Pettila, V., Webb, S.A., Bailey, M., Howe, B., Seppelt, I.M., Acute kidney injury and 2009 H1N1 influenza-related critical illness. Contrib Nephrol 165 (2010), 310–314.
7. [7] Armstrong, S.M., Mubareka, S., Lee, W.L., The lung microvascular endothelium as a therapeutic target in severe influenza. Antiviral Res 99 (2013 Aug), 113–118.
8. [8] Chutinimitkul, S., Bhattarakosol, P., Srisuratanon, S., Eiamudomkan, A., Kongsomboon, K., Damrongwatanapokin, S., et al. H5N1 influenza A virus and infected human plasma. Emerg Infect Dis 12 (2006 Jun), 1041–1043.
9. [9] Gao, R., Dong, L., Dong, J., Wen, L., Zhang, Y., Yu, H., et al. A systematic molecular pathology study of a laboratory confirmed H5N1 human case. PLoS One, 5, 2010, e13315.
10. [10] Gao, R., Bhatnagar, J., Blau, D.M., Greer, P., Rollin, D.C., Denison, A.M., et al. Cytokine and chemokine profiles in lung tissues from fatal cases of 2009 pandemic influenza A (H1N1): role of the host immune response in pathogenesis. Am J Pathol 183 (2013 Oct), 1258–1268.
11. [11] Harms, P.W., Schmidt, L.A., Smith, L.B., Newton, D.W., Pletneva, M.A., Walters, L.L., et al. Autopsy findings in eight patients with fatal H1N1 influenza. Am J Clin Pathol 134 (2010 Oct), 27–35.
12. [12] Mauad, T., Hajjar, L.A., Callegari, G.D., da Silva, L.F., Schout, D., Galas, F.R., et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Resp Critical Care Med 181 (2010 Jan 1), 72–79.
13. [13] Shieh, W.J., Blau, D.M., Denison, A.M., Deleon-Carnes, M., Adem, P., Bhatnagar, J., et al. 2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol 177 (2010 Jul), 166–175.
14. [14] Arankalle, V.A., Lole, K.S., Arya, R.P., Tripathy, A.S., Ramdasi, A.Y., Chadha, M.S., et al. Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PloS One, 5, 2010.
15. [15] Martinez-Orellana, P., Martorell, J., Vidana, B., Majo, N., Martinez, J., Falcon, A., et al. Clinical response to pandemic H1N1 influenza virus from a fatal and mild case in ferrets. Virol J, 12, 2015, 48.